Interpreting HIV seroprevalence data from pregnant women

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue 5, 1996, Pages 434-439

  Boisson, Eldonna ^a   Nicoll, Angus ^b   Zaba, Basia ^a   Rodrigues, Laura C ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Fertility risk; Human immunodeficiency virus; Human immunodeficiency virus infection risk; Seroprevalence; Women

Indexed keywords

ADULT; ARTICLE; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE DEFICIENCY; INFECTION RISK; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SERODIAGNOSIS; SEXUALLY TRANSMITTED DISEASE; VIRUS INFECTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030475649     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199612150-00006     Document Type: Article

References (29)

1. PANOS. AIDS: towards 2000. In: PANOS AIDS media briefing. London: Panos, 1994.
2. Public Health Laboratory Service. AIDS and HIV-1 infection in the United Kingdom: monthly report. Communicable Dis Rep 1995;5:13-6.
3. Centers for Disease Control and Prevention. AIDS among women - United States, 1994. MMWR 1995;44:81-4.
4. Ankrah EM. The impact of HIV/AIDS on the family and other significant relationships: the African clan revisited. AIDS Care 1993;5:5-22.
5. Hunter SS. Orphans as a window on the AIDS epidemic in Sub-Saharan Africa: initial results and implications of a study in Uganda. Soc Sci Med 1990;31:681-90.
6. Thorne C, Newell ML, Dunn D, Peckham C. Characteristics of pregnant HIV-1 infected women in Europe. AIDS Care 1996;8:33-42.
7. World Health Organization/Global Programme on AIDS. The HIV/AIDS pandemic: 1994 overview. Global Programme on AIDS, 1994, WHO/GPA/TCO/SEF, 94.4:1-16.
8. Report of an Expert Group. The incidence and prevalence of AIDS and other severe HIV disease in England and Wales for 1995-1999: projections using data to the end of 1994. Communicable Dis Rep 1996;6:R1-24.
9. Ryder RW, Batter VL, Nsuami M, et al. Fertility rates in 238 HIV-1-seropositive women in Zaire followed for 3 years postpartum. AIDS 1991;5:1521-7.
10. Berkley S, Naamara W, Okware S, et al. AIDS and HIV infection in Uganda - are more women infected than men? AIDS 1990;4:1237-42.
11. Centers for Disease Control. Pilot study of a household survey to determine HIV seroprevalence. MMWR 1991;40:1-5.
12. Adler MW, Gill ON, Day NE. Monitoring the prevalence of HIV: foundations for a programme of unlinked anonymous testing in England and Wales. Br Med J 1989;299:1295-8.
13. Hull HF, Bettinger CJ, Gallaher MM, Keller NM, Wilson J, Mertz GJ. Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic. Br Med J 1989;298:419-22.
14. Unlinked Anonymous HIV Surveys Steering Group. Unlinked Anonymous HIV Prevalence Monitoring Programme: England and Wales, data to the end of 1993. London: Department of Health, Public Health Laboratory Service, Institute of Child Health, 1995.
15. Dondero TJ, Gill ON. Large-scale HIV serologic surveys: what has been learned? AIDS 1991;5(suppl):S63-9.
16. Chin J. Public health surveillance of AIDS and HIV infection. Bull WHO 1990;68:592-36.
17. Pappaioanou M, Kashamuka M, Behets F. Accurate detection of maternal antibodies to HIV in newborn whole blood dried on filter paper. AIDS 1993;7:483-8.
18. United States Bureau of the Censuses, Health Studies Branch, Center for International Research. Recent HIV seroprevalence levels by country. Washington, D.C.: U.S. Government, 1993.
19. European HIV Prevalence Database (updated version July 1995). European Centre for the Epidemiological Monitoring of AIDS, Paris, 1995.
20. Ades AE, Parker S, Berry T, et al. Prevalence of maternal HIV-1 infection in Thames regions: results from anonymous unlinked neonatal testing. Lancet 1991;337:1562-5.
21. Gwinn M, Redus MA, Granade TC, Hannon WH, George JR. HIV-1 serologic test results for one million newborn dried blood specimens: assay performance and implications for screening. J Acquir Immune Defic Syndr 1992;5:505-12.
22. Giesecke J, Johnson A, Hawkins A, et al. An estimate of the prevalence of human immunodeficiency virus infection in England and Wales by using a direct method. J R Stat Soc 1994;157:89-103.
23. Rosenberg PS, Levy ME, Brundage JF, et al. Population-based monitoring of an urban HIV/AIDS epidemic; magnitude and trends in the district of Columbia. JAMA 1992;268:495-503.
24. Kigadye R-M, Klokke A, Nicoll A, et al. Sentinel surveillance for HIV-1 amongst pregnant women in a developing country: 3 years' experience and comparison with a population serosurvey. AIDS 1993;7:849-55.
25. Chrystie IL, Palmer SJ, Kenney A, Banatvala JE. HIV seroprevalence among women attending antenatal clinics in London. Lancet 1992;339:364.
26. Ades AE, Parker S, Cubitt D, et al. Two methods for assessing the risk-factor composition of the HIV-1 epidemic in heterosexual women: southeast England, 1988-1991. AIDS 1992;6:1031-6.
27. Swan AV, Nicoll A, McGarrigle C, Noone A, Gill ON. An investigation assessing the fraction of human immunodeficiency virus infection attributable to ethnic group variations in risk. Int J Epidemiol 1995;24(suppl 1):S15-20.
28. Office of Population Censuses and Surveys. Birth statistics. Review of the Registrar General on births and patterns of family building in England and Wales, 1991. Series FM1 no. 20. London: HMSO, 1991.
29. Ades AE. Serial HIV seroprevalence surveys: interpretation, design, and role in HIV/AIDS prediction. J Acquir Immune Defic Syndr 1995;9:490-9.